SOLAR BIOTECH, INC. – Trademark Portfolio
Entity Type: 03
SOLAR BIOTECH, INC. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 7 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 2 trademarks are registered and 5 are pending. Notable registered marks include SOLAR BIOTECH. The owner is based in NORTON, VA.
5516 INDUSTRIAL PARK RD.
NORTON, VA 24273
Showing of trademarks Trademarks
Trademark Classifications
SOLAR BIOTECH, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does SOLAR BIOTECH, INC. have?
SOLAR BIOTECH, INC. has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 pending, 1 abandoned.
What trademark classes does SOLAR BIOTECH, INC. file in?
SOLAR BIOTECH, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing). Class 42 covers scientific and technological services; industrial analysis and research services.
What are SOLAR BIOTECH, INC.'s most well-known trademarks?
SOLAR BIOTECH, INC.'s registered trademark portfolio includes well-known marks such as SOLAR BIOTECH. These are among 2 currently registered trademarks in the portfolio.
What is SOLAR BIOTECH, INC.'s trademark registration success rate?
SOLAR BIOTECH, INC. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 5 applications are pending review.